Achieving a successful transplant outcome is a team effort. From organ intake management to waitlist management, it’s a complex journey to get a life-saving transplant—whether it be a kidney or lung—to the lucky person receiving it. The stories around transplants going from donors to recipients are deeply emotional and inspiring.
OmniLife Health is a Keyhorse-backed company with a platform that transforms the organ transplant journey by simplifying clinical workflows and standardizing complex care pathways. OmniLife’s platform, FlowHawk, lets care teams access data and insights that help them improve productivity, manage staff, and optimize billing.
We asked the company’s co-founder and CEO, Dalton Shaull, a few questions about his journey, inspirations, and predictions for the future of software in healthcare.
How did you become interested in workflow management for organ transplantation?
DS: I had the experience of spending four years working with our hospital partners and clients. Our product is an evolution of being customer-centric and agile to adapt to the evolving market, follow the money, and try to build value and ROI for our early clients.
What inspired you to co-found a company?
DS: There are several: I was inspired by my tissue transplant, my co-founder Eric’s family struggles with liver failure and disease, my uncle is a transplant surgeon, and a family friend’s three-year-old child needed a heart transplant to survive.
Staffing shortages, mass consolidation of primary care, aging population, increases in complex care cases driven by heart disease, diabetes/CKD/ESRD, lung disease (accelerated by CV19), complex cancers, and increased remote/out-patient care all result in an increased need for collaborative care.
Tell us about your team: Who’s on it, and how did you meet?
DS: My co-founder Eric Pahl and I met at the University of Iowa at an entrepreneurial networking event. Dyan Bymark, our Chief Commercial Officer, joined in 2022. Her sister received a life-saving liver transplant. Dyan came from Teladoc Health and has over 10 years of startup health IT experience with three successful exits. Jake Sorg, our interim COO/advisor, came from Symplr Health and has over 30 years of Health IT experience with five exits. Before Symplr, Jake served at Trizzeto, which was acquired by Cognizant, and served as VP of National Practices at Cerner Corporation, which was acquired by Oracle. Matt Stafford, our SVP of sales, joined in 2022. He has over 10 years of selling into the hospital provider markets and extensive experience in organ failure/complex care. You can read more bios and get to know other team members here.
Where do you see healthcare-related software headed in the near future?
DS: Staffing shortages, mass consolidation of primary care, aging population, increases in complex care cases driven by heart disease, diabetes/CKD/ESRD, lung disease (accelerated by CV19), complex cancers, and increased remote/out-patient care all result in an increased need for collaborative care. All of this is driving a systematic demand for improved care coordination and communication.
What does success look like to OmniLife Health in the short term and long term?
DS: OmniLife Health is the #1 care collaboration and clinical workflow automation platform for complex care. This means that OmniLife leverages its first-mover advantage to dominate/monopolize the organ failure market and as a result, grows into other complex care verticals within hospitals, health systems, IDNs, and ACOs—starting with oncology.